Vascular protective effects of ezetimibe in ApoE-deficient mice

Atherosclerosis

Volumn 203, Issue 1, 2009, Pages 51-58

  Nakagami, Hironori ^a   Osako, Mariana Kiomy ^a   Takami, Yoichi ^a   Hanayama, Rie ^a   Koriyama, Hiroshi ^a   Mori, Masaki ^a   Hayashi, Hiroki ^a   Shimizu, Hideo ^a   Morishita, Ryuichi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

ApoE; Cholesterol absorption; Endothelial function; Ezetimibe

Indexed keywords

APOLIPOPROTEIN E; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EZETIMIBE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; INTERLEUKIN 6; MESSENGER RNA; PROTEASOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENDOTHELIAL DYSFUNCTION; HYPERLIPIDEMIA; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTECTION; UBIQUITINATION;

ANIMAL FEED; ANIMALS; ANTICHOLESTEREMIC AGENTS; APOLIPOPROTEINS E; AZETIDINES; CHOLESTEROL, HDL; DIETARY FATS; ETHIDIUM; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, BIOLOGICAL; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS;

EID: 60649083150     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.05.026     Document Type: Article

References (22)

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
2. Grundy S.M. Absorption and metabolism of dietary cholesterol. Annual Review of Nutrition 3 (1983) 71-96
3. Van Heek M., France C.F., Compton D.S., et al. In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461. The Journal of Pharmacology and Experimental Therapeutics 283 (1997) 157-163
4. Rosenblum S.B., Huynh T., Afonso A., et al. Discovery of 1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S)-(4-hydroxyphenyl)-2-azetidinone (SCH 58235): a designed, potent, orally active inhibitor of cholesterol absorption. Journal of Medicinal Chemistry 41 (1998) 973-980
5. van Heek M., Compton D.S., and Davis H.R. The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys. European Journal of Pharmacology 415 (2001) 79-84
6. Altmann S.W., Davis Jr. H.R., Zhu L.J., et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science (New York, NY) 303 (2004) 1201-1204
7. Garcia-Calvo M., Lisnock J., Bull H.G., et al. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 8132-8137
8. Davis H.R., and Veltri E.P. Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia. Journal of Atherosclerosis and Thrombosis 14 (2007) 99-108
9. Davis Jr. H.R., Zhu L.J., Hoos L.M., et al. Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. The Journal of Biological Chemistry 279 (2004) 33586-33592
10. Davis Jr. H.R., Hoos L.M., Tetzloff G., et al. Deficiency of Niemann-Pick C1 Like 1 prevents atherosclerosis in ApoE-/- mice. Arteriosclerosis, Thrombosis, and Vascular Biology 27 (2007) 841-849
11. Hayashi K., Nakamura S., Morishita R., et al. In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model. Gene Therapy 7 (2000) 1664-1671
12. Nakai A., Yamaguchi O., Takeda T., et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nature Medicine 13 (2007) 619-624
13. Barry-Lane P.A., Patterson C., van der Merwe M., et al. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. Journal of Clinical Investigation 108 (2001) 1513-1522
14. Davis Jr. H.R., Compton D.S., Hoos L., and Tetzloff G. Ezetimibe a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice. Arteriosclerosis, Thrombosis, and Vascular Biology 21 (2001) 2032-2038
15. Treasure C.B., Klein J.L., Weintraub W.S., et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. New England Journal of Medicine 332 (1995) 481-487
16. Laufs U., and Liao J.K. Direct vascular effects of HMG-CoA reductase inhibitors. Trends in Cardiovascular Medicine 10 (2000) 143-148
17. Marfella R., D'Amico M., Di Filippo C., et al. Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment. Journal of the American College of Cardiology 47 (2006) 2444-2455
18. Versari D., Herrmann J., Gossl M., et al. Dysregulation of the ubiquitin-proteasome system in human carotid atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 26 (2006) 2132-2139
19. Lai P.F., Mohamed F., Monge J.C., and Stewart D.J. Downregulation of eNOS mRNA expression by TNFalpha: identification and functional characterization of RNA-protein interactions in the 3′UTR. Cardiovascular Research 59 (2003) 160-168
20. Anderson H.D., Rahmutula D., and Gardner D.G. Tumor necrosis factor-alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells. The Journal of Biological Chemistry 279 (2004) 963-969
21. Deushi M., Nomura M., Kawakami A., et al. Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome. FEBS Letters 581 (2007) 5664-5670
22. Assy N., Grozovski M., Bersudsky I., Szvalb S., and Hussein O. Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease. World Journal of Gastroenterology 12 (2006) 4369-4376